“…Over 15 years of clinical data support enhanced therapeutic properties for autologous‐sourced cell sheets through increased cell retention at target tissues (Ebihara et al, 2012; Iwata et al, 2018; Kanzaki, Takagi, Washio, Kokubo, & Yamato, 2017; Nishida et al, 2004; Ohki et al, 2012; Sawa et al, 2015; Yamaguchi et al, 2017; Yamamoto et al, 2017). Recently, several preclinical studies have also reported MSC sheet use in wound healing, heart, and pancreas regeneration (Kato et al, 2015; Kim et al, 2018; Miyahara et al, 2006). However, for reliable clinical performance and regulatory acceptance, standardized MSC sheet fabrication methods yielding reproducible cell‐based products with quality control specifications must first be developed.…”